Divi’s Laboratories announced a robust financial performance for the March quarter of FY25, with a 25.6% YoY surge in standalone net profit, reaching Rs 667 crore. Revenue from operations also climbed by 12.26% to Rs 2,536 crore. The company’s board declared a dividend of Rs 30 per share and its Unit III greenfield project has commenced commercial operations.
US Stock Market Today | Dow Jones | Nasdaq Live: S&P 500, Nasdaq futures edge up as investors weigh Iran war developments
Dow Jones Today | Nasdaq | S&P 500 | US Stock Market Live Updates: At 7:13 a.m. ET, Dow E-minis were down 62 points, or